Strategy Asset Managers’s Boston Scientific BSX Stock Holding History

Strategy Asset Managers’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$682K	Sell	10,876 -9,134	-46%	-$731K	0.11%	132
2025 Q4	$1.91M	Buy	20,010 +527	+3%	+$51.7K	0.31%	66
2025 Q3	$1.9M	Sell	19,483 -233	-1%	-$24.1K	0.34%	61
2025 Q2	$2.12M	Sell	19,716 -109	-0.5%	-$11K	0.4%	58
2025 Q1	$2M	Buy	19,825 +399	+2%	+$40.2K	0.41%	59
2024 Q4	$1.74M	Sell	19,426 -814	-4%	-$71.7K	0.34%	62
2024 Q3	$1.7M	Buy	20,240 +12,265	+154%	+$967K	0.33%	62
2024 Q2	$431K	Sell	7,975 -2,464	-24%	-$180K	0.1%	147
2024 Q1	$715K	Buy	10,439 +1,605	+18%	+$103K	0.15%	109
2023 Q4	$511K	Buy	8,834 +153	+2%	+$8.17K	0.12%	126
2023 Q3	$458K	Buy	8,681 +706	+9%	+$37K	0.12%	132
2023 Q2	$431K	Sell	7,975 -187	-2%	-$9.77K	0.1%	147
2023 Q1	$408K	Buy	8,162 +331	+4%	+$15.6K	0.1%	143
2022 Q4	$362K	Sell	7,831 -54	-0.7%	-$2.34K	0.09%	162
2022 Q3	$305K	Buy	+7,885	New	+$316K	0.08%	172
2022 Q1	–	Sell	-8,108	Closed	-$344K	–	255
2021 Q4	$344K	Buy	+8,108	New	+$341K	0.09%	143
2019 Q2	–	Sell	-480	Closed	-$18K	–	132
2019 Q1	$18K	Sell	480 -48,383	-99%	-$1.85M	﹤0.01%	178
2018 Q4	$1.73M	Sell	48,863 -43,191	-47%	-$1.57M	0.42%	60
2018 Q3	$3.54M	Buy	+92,054	New	+$3.22M	0.72%	34
2016 Q4	–	Sell	-104,095	Closed	-$2.48M	–	129
2016 Q3	$2.48M	Buy	+104,095	New	+$2.48M	0.56%	64
2016 Q1	–	Sell	-131,461	Closed	-$2.42M	–	143
2015 Q4	$2.42M	Buy	131,461 +281	+0.2%	+$5.04K	0.55%	61
2015 Q3	$2.15M	Buy	+131,180	New	+$2.24M	0.52%	64

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Strategy Asset Managers's BSX Position: Q1 2026 in Review

Strategy Asset Managers reduced its Boston Scientific (BSX) stake by 46% in Q1 2026, selling an estimated $731K and leaving 10,876 shares worth $682K. The position accounts for 0.11% of the portfolio, ranked #132.

Strategy Asset Managers first reported a position in BSX in Q3 2015 and has held it in 22 quarters since. The position peaked at $3.54M in Q3 2018. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Strategy Asset Managers held 10,876 shares of Boston Scientific worth $682K as of Q1 2026.
Strategy Asset Managers sold 9,134 Boston Scientific shares in Q1 2026, an estimated $731K.
Boston Scientific made up 0.11% of Strategy Asset Managers's portfolio in Q1 2026, its #132 holding.
Strategy Asset Managers first reported a position in Boston Scientific in Q3 2015 and has held it in 22 quarters since.
Strategy Asset Managers's Boston Scientific position peaked at $3.54M in Q3 2018.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Strategy Asset Managers's 13F filing for Q1 2026, filed 12 May 2026.